This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various biologically active molecules. Its structure is particularly valuable in the development of pharmaceutical agents, especially those targeting neurological disorders. The methanesulfonyl group enhances the compound's reactivity, making it a versatile building block for creating complex molecules with potential therapeutic effects. Researchers often employ it in the design and synthesis of compounds that interact with specific receptors or enzymes in the brain, contributing to the development of drugs for conditions such as depression, anxiety, and neurodegenerative diseases. Additionally, its stability and functional groups make it suitable for further chemical modifications, enabling the exploration of new drug candidates in preclinical studies.